Investigation of Inspire Medical Systems, Inc.
Pomerantz LLP is conducting a thorough investigation regarding claims on behalf of investors of Inspire Medical Systems, Inc. (NASDAQ: INSP). This inquiry seeks to determine if the company and certain officers or directors may have engaged in securities fraud or other unlawful business practices.
Company Financial Outlook
Recently, Inspire Medical Systems issued an announcement revealing a substantially revised financial outlook for the upcoming years. They adjusted their expectations for total revenue down to the range of $900 million to $910 million, substantially below the prior guidance which forecasted $940 million to $955 million. Furthermore, the diluted net income per share is now anticipated to be between $0.40 and $0.50, compared to earlier estimates of $2.20 to $2.30.
Impact of the New Financial Guidance
This news comes as a shock to investors, given that the reduced guidance stems from slower-than-expected progress in the commercial rollout of their innovative Inspire V neurostimulation system. Due to this announcement, the stock price of Inspire Medical Systems dramatically declined by over 32% in a single day, closing at $87.91 per share, down $42.04.
Pomerantz Law Firm's Role
Pomerantz LLP, based in New York, Chicago, and other major cities, stands out as a leader in corporate, securities, and antitrust litigation. Established by the renowned Abraham L. Pomerantz, the firm has been at the forefront of securities class action lawsuits for over eight decades. Pomerantz has successfully recovered numerous damages awards for victims of securities fraud and corporate misconduct.
Continuous Support for Investors
Understanding the complexities of securities fraud and corporate misconduct can be daunting. Pomerantz LLP is committed to assisting investors affected by any unlawful practices related to Inspire Medical Systems. They encourage investors to reach out for support or to inquire further about their rights.
Contact Information
For those affected or interested in learning more about this investigation, contact Danielle Peyton at Pomerantz LLP via phone at 646-581-9980, ext. 7980 or email at dpeyton@pomlaw.com.
Frequently Asked Questions
What is the purpose of the investigation by Pomerantz LLP?
The investigation aims to explore potential securities fraud or unlawful business practices in relation to Inspire Medical Systems, Inc.
How has Inspire Medical Systems' stock been affected?
The stock plummeted by over 32% following the announcement of a revised financial outlook, signaling significant investor concern.
What changes were made to Inspire's financial outlook?
Inspire reduced their full-year revenue estimates and earnings per share projections, reflecting challenges in their product launch.
Who can I contact for more information about the investigation?
Interested parties can reach out to Danielle Peyton at Pomerantz LLP for inquiries regarding the investigation.
What has Pomerantz LLP achieved historically?
Pomerantz has a rich history of recovering substantial damages for victims of corporate fraud and remains a key player in the class action litigation field.
